Interobserver variability between cytopathologists and cytotechnologists upon application and characterization of the indeterminate category in the Milan System for Reporting Salivary Gland Cytopathology.
Adolescent
Adult
Aged
Aged, 80 and over
Biopsy, Fine-Needle
Child
Child, Preschool
Cytodiagnosis
/ standards
Female
Follow-Up Studies
Humans
Infant
Male
Middle Aged
Observer Variation
Prognosis
Reproducibility of Results
Retrospective Studies
Salivary Gland Neoplasms
/ classification
Salivary Glands
/ pathology
Young Adult
Milan system
cytopathologist
cytotechnologist
fine-needle aspiration
indeterminate
interobserver variability
salivary gland
Journal
Cancer cytopathology
ISSN: 1934-6638
Titre abrégé: Cancer Cytopathol
Pays: United States
ID NLM: 101499453
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
28
03
2020
revised:
26
05
2020
accepted:
28
05
2020
pubmed:
24
6
2020
medline:
24
2
2021
entrez:
24
6
2020
Statut:
ppublish
Résumé
The indeterminate categories in the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) are diagnostically challenging because of inherent heterogeneity and complexity, with wide interobserver variability (IOV). Herein, the authors explore the concordance rate (CR) between cytopathologists (CPs) and cytotechnologists (CTs) in interpreting indeterminate salivary gland lesions using the MSRSGC. Between 2011 and 2016, 86 indeterminate fine-needle aspirations had slides available for review, of which 48 had follow-up. Four CPs and 2 CTs performed an independent, blinded review of these slides and categorized them according to the MSRSGC. The CRs between CTs and CPs with the final sign-out cytopathologist (FCP) were assessed, and interobserver agreement was categorized into uniform, majority, divided, minimal, or no agreement. The overall CR with the FCP ranged from 48.8% to 60.5% for CPs and from 22.1% to 36% for CTs. IOV κ scores for the entire group were 0.314 and, with the FCP as the reference, ranged from 0.403 to 0.539 for CPs and from 0.091 to 0.254 for CTs. Uniform, majority, divided, minimal, and no agreement was noted in 12.8%, 31.4%, 38.4%, 10.5%, and 6.9%, respectively, of all cases and in 16.7%, 35.4%, 31.3%, 8.3%, and 6.3%, respectively, of the cases with follow-up. Diagnostic challenges included distinguishing lymphoma from a reactive process and distinguishing mucin from mucin-like material. CPs had modestly higher CRs compared with CTs; and, although the variable CRs highlight indeterminate IOV, the MSRSGC enables reproducibility. Characterizing larger cohorts in the indeterminate categories will further improve MSRSGC criteria. Moreover, education on the MSRSGC should include CTs and CPs to improve overall diagnostic accuracy.
Sections du résumé
BACKGROUND
The indeterminate categories in the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) are diagnostically challenging because of inherent heterogeneity and complexity, with wide interobserver variability (IOV). Herein, the authors explore the concordance rate (CR) between cytopathologists (CPs) and cytotechnologists (CTs) in interpreting indeterminate salivary gland lesions using the MSRSGC.
METHODS
Between 2011 and 2016, 86 indeterminate fine-needle aspirations had slides available for review, of which 48 had follow-up. Four CPs and 2 CTs performed an independent, blinded review of these slides and categorized them according to the MSRSGC. The CRs between CTs and CPs with the final sign-out cytopathologist (FCP) were assessed, and interobserver agreement was categorized into uniform, majority, divided, minimal, or no agreement.
RESULTS
The overall CR with the FCP ranged from 48.8% to 60.5% for CPs and from 22.1% to 36% for CTs. IOV κ scores for the entire group were 0.314 and, with the FCP as the reference, ranged from 0.403 to 0.539 for CPs and from 0.091 to 0.254 for CTs. Uniform, majority, divided, minimal, and no agreement was noted in 12.8%, 31.4%, 38.4%, 10.5%, and 6.9%, respectively, of all cases and in 16.7%, 35.4%, 31.3%, 8.3%, and 6.3%, respectively, of the cases with follow-up. Diagnostic challenges included distinguishing lymphoma from a reactive process and distinguishing mucin from mucin-like material.
CONCLUSIONS
CPs had modestly higher CRs compared with CTs; and, although the variable CRs highlight indeterminate IOV, the MSRSGC enables reproducibility. Characterizing larger cohorts in the indeterminate categories will further improve MSRSGC criteria. Moreover, education on the MSRSGC should include CTs and CPs to improve overall diagnostic accuracy.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
828-839Informations de copyright
© 2020 American Cancer Society.
Références
Layfield LJ, Glasgow BJ. Diagnosis of salivary gland tumors by fine-needle aspiration cytology: a review of clinical utility and pitfalls. Diagn Cytopathol. 1991;7:267-272.
Layfield LJ, Tan P, Glasgow BJ. Fine-needle aspiration of salivary gland lesions. Comparison with frozen sections and histologic findings. Arch Pathol Lab Med. 1987;111:346-353.
Mairembam P, Jay A, Beale T, et al. Salivary gland FNA cytology: role as a triage tool and an approach to pitfalls in cytomorphology. Cytopathology. 2016;27:91-96.
Seethala RR, LiVolsi VA, Baloch ZW. Relative accuracy of fine-needle aspiration and frozen section in the diagnosis of lesions of the parotid gland. Head Neck. 2005;27:217-223.
Rohilla M, Singh P, Rajwanshi A, et al. Three-year cytohistological correlation of salivary gland FNA cytology at a tertiary center with the application of the Milan system for risk stratification. Cancer Cytopathol. 2017;125:767-775.
Rossi ED, Wong LQ, Bizzarro T, et al. The impact of FNAC in the management of salivary gland lesions: institutional experiences leading to a risk-based classification scheme. Cancer Cytopathol. 2016;124:388-396.
Faquin WC, Rossi ED, Baloch Z, et al. The Milan System for Reporting Salivary Gland Cytopathology. Springer International Publishing AG; 2018.
Viswanathan K, Sung S, Scognamiglio T, Yang GCH, Siddiqui MT, Rao RA. The role of the Milan System for Reporting Salivary Gland Cytopathology: a 5-year institutional experience. Cancer Cytopathol. 2018;126:541-551.
Rossi ED, Faquin WC. The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC): an international effort toward improved patient care-when the roots might be inspired by Leonardo da Vinci. Cancer Cytopathol. 2018;126:756-766.
Wang H, Malik A, Maleki Z, et al. “Atypical” salivary gland fine needle aspiration: risk of malignancy and interinstitutional variability. Diagn Cytopathol. 2017;45:1088-1094.
Griffith CC, Schmitt AC, Pantanowitz L, Monaco SE. A pattern-based risk-stratification scheme for salivary gland cytology: a multi-institutional, interobserver variability study to determine applicability. Cancer Cytopathol. 2017;125:776-785.
Kurtycz DFI, Rossi ED, Baloch Z, et al. Milan Interobserver Reproducibility Study (MIRST): Milan system 2018. J Am Soc Cytopathol. 2020;9:116-125.
Hollyfield JM, O'Connor SM, Maygarden SJ, et al. Northern Italy in the American South: assessing interobserver reliability within the Milan System for Reporting Salivary Gland Cytopathology. Cancer Cytopathol. 2018;126:390-396.
Garg N, Diwaker P, Pathak P, Aggarwal D, Arora VK. Implementation of the Milan System for Reporting Salivary Gland Cytopathology: interobserver concordance and cytohistological correlation of discordant cases. Diagn Cytopathol. 2019;47:769-775.
Baloch ZW, Faquin WC, Layfield LJ. Is it time to develop a tiered classification scheme for salivary gland fine-needle aspiration specimens? Diagn Cytopathol. 2017;45:285-286.
Bajwa MS, Rose SJ, Mairembam P, et al. Feasibility of a novel classification for parotid gland cytology: a retrospective review of 512 cytology reports taken from 4 United Kingdom general hospitals. Head Neck. 2016;381:1596-1603.
Griffith CC, Pai RK, Schneider F, et al. Salivary gland tumor fine-needle aspiration cytology: a proposal for a risk stratification classification. Am J Clin Pathol. 2015;143:839-853.
Rossi ED, Baloch Z, Pusztaszeri M, Faquin WC. The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC): an ASC-IAC-sponsored system for reporting salivary gland fine needle aspiration. J Am Soc Cytopathol. 2018;7:111-118.
Maleki Z, Baloch Z, Lu R, et al. Application of the Milan System for Reporting Submandibular Gland Cytopathology: an international, multi-institutional study. Cancer Cytopathol. 2019;127:306-315.
Miller JA, An D, Shafique K, et al. Mucoepidermoid carcinoma, acinic cell carcinoma, and adenoid cystic carcinoma on fine-needle aspiration biopsy and The Milan System: an international multi-institutional study. J Am Soc Cytopathol. 2019;8:270-277.
Song SJ, Shafique K, Wong LQ, LiVolsi VA, Montone KT, Baloch Z. The utility of the Milan system as a risk stratification tool for salivary gland fine needle aspiration cytology specimens. Cytopathology. 2019;30:91-98.
Layfield LJ, Esebua M, Yang Z, Vatzmitsel M, Giorgadze T, Schmidt R. The Milan System for Reporting Salivary Gland Cytopathology: a study of inter-observer reproducibility. Diagn Cytopathol. 2019;47:765-768.
Liu H, Ljungren C, Lin F, Zarka MA, Chen L. Analysis of histologic follow-up and risk of malignancy for salivary gland neoplasm of uncertain malignant potential proposed by the Milan System for Reporting Salivary Gland Cytopathology. Cancer Cytopathol. 2018;126:490-497.
Griffith CC, Siddiqui MT, Schmitt AC. Ancillary testing strategies in salivary gland aspiration cytology: a practical pattern-based approach. Diagn Cytopathol. 2017;45:808-819.
Maleki Z, Miller JA, Arab SE, et al. “Suspicious” salivary gland FNA: risk of malignancy and interinstitutional variability. Cancer Cytopathol. 2018;126:94-100.